In this case study Dr. Evandro de Azambuja discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description Female, 77 years old, postmenopausal Hypertension , dyslipidemia, gastritis (AAS, bisoprolol, pantoprazole and atorvastatine) Case history July 2014: Tumorectomy cT2N0M0 invasive ductal carcinoma, HR + (ER/PR 8/8), HER2 neg (IHC […]

In this case study Dr. José Bines discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description 25 yow, premenopausal, single, architecture student, without comorbidities. Family history includes a paternal grandmother and 2 paternal aunts with breast cancer at a young age. A gBRCA2 pathogenic mutation was documented.

In this case study Dr. Evandro de Azambuja discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description Female, 77 years old, postmenopausal Hypertension , dyslipidemia, gastritis (AAS, bisoprolol, pantoprazole and atorvastatine) Case history July 2014: Tumorectomy cT2N0M0 invasive ductal carcinoma, HR + (ER/PR 8/8), HER2 neg (IHC

In this case study Dr. Mattea Reinisch discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: Patient description 57-year-old lady, 2 children (20 and 24 years), she works as a teacher for German and History Postmenopausal Family history: Aunt with breast cancer, age of 55 years Brother Colon cancer,

In this case study Dr. Rachel Würstlein discusses the clinical potential of CDK4/6 inhibitors in Breast Cancer. Take the Case Study Quiz: What is the most common side effects of Abemaciclib? QT prolongation Fatigue Neutropenia Diarrhea Elevated liver enzymes None Time’s upCancel